PHRM — Pharmather Holdings Balance Sheet
0.000.00%
- CA$10.47m
- CA$9.43m
Annual balance sheet for Pharmather Holdings, fiscal year end - May 31st, CAD millions except per share, conversion factor applied.
2021 May 31st | 2022 May 31st | 2023 May 31st | 2024 May 31st | 2025 May 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 5.88 | 12.1 | 6.25 | 2.3 | 1.12 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.029 | 0.03 | 0.056 | 0.023 | 0.016 |
| Prepaid Expenses | |||||
| Total Current Assets | 5.94 | 12.2 | 6.31 | 2.34 | 1.14 |
| Net Property, Plant And Equipment | 0.004 | 0.002 | 0.001 | 0 | — |
| Long Term Investments | |||||
| Total Assets | 5.94 | 12.2 | 6.31 | 2.59 | 1.34 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.176 | 0.33 | 0.892 | 0.253 | 0.366 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Liabilities | 0.361 | 0.33 | 0.892 | 0.253 | 0.366 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 5.58 | 11.8 | 5.42 | 2.34 | 0.974 |
| Total Liabilities & Shareholders' Equity | 5.94 | 12.2 | 6.31 | 2.59 | 1.34 |
| Total Common Shares Outstanding |